Cumberland Pharmaceuticals (CPIX) Reports Q3 Loss of $0.06

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q3 EPS of ($0.06). Revenue for the quarter came in at $8.3 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Hawaiian Electric trades at 8.8x P/E, but wildfire risk clouds value case
• Five Below (FIVE) call put ratio 1 call to 1.3 puts into quarter results
• Morgan Stanley upgrades Robinhood, sees 43% upside